Literature DB >> 15761471

The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm.

L M Bender1, M J Morgan, L R Thomas, Z-G Liu, A Thorburn.   

Abstract

TNFR1 associated death domain protein (TRADD) contains an N-terminal TRAF binding domain and a C-terminal death domain along with nuclear import and export sequences that cause shuttling between the cytoplasm and nucleus. The death domain of TRADD contains the nuclear import sequence and expression of the core death domain (nuclear TRADD) results in exclusive nuclear localization and activation of a distinct apoptotic pathway. Cytoplasmic TRADD activates apoptosis through Fas-associated death domain protein (FADD) and caspase-8 activation that was blocked by caspase inhibitors or dominant-negative FADD. These inhibitors did not inhibit death induced by nuclear TRADD, which could only be inhibited by combining caspase inhibitors and a serine protease inhibitor. The pathway activated by nuclear TRADD requires caspase-9 catalytic activity. However, apoptosis activating factor deficiency confers only partial protection from death. This pathway represents an alternate means by which TRADD can regulate cell death independently of FADD and caspase-8 that occurs from the nucleus rather than the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761471     DOI: 10.1038/sj.cdd.4401578

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  23 in total

Review 1.  The role of glutamate and its receptors in multiple sclerosis.

Authors:  Ivana R Stojanovic; Milos Kostic; Srdjan Ljubisavljevic
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

Review 2.  Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death.

Authors:  Vikas Anathy; Elle C Roberson; Amy S Guala; Karolyn E Godburn; Ralph C Budd; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2011-12-22       Impact factor: 8.401

Review 3.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

4.  NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK.

Authors:  Anuja Chattopadhyay; Irina Abecassis; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2015-10-05

5.  Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion.

Authors:  Xuemei Tong; Pierre A Coulombe
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

6.  Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.

Authors:  Anuja Chattopadhyay; Brian L Hood; Thomas P Conrads; Robert L Redner
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

Review 7.  Hypoxia ischemia-mediated cell death in neonatal rat brain.

Authors:  Martin B Gill; J Regino Perez-Polo
Journal:  Neurochem Res       Date:  2008-04-12       Impact factor: 3.996

8.  Intestinal edema: effect of enteral feeding on motility and gene expression.

Authors:  Stacey D Moore-Olufemi; Jeff Padalecki; Shodimu E Olufemi; Hasen Xue; Dwight H Oliver; Ravi S Radhakrishnan; Steve J Allen; Fred A Moore; Randy Stewart; Glen A Laine; Charles S Cox
Journal:  J Surg Res       Date:  2008-10-24       Impact factor: 2.192

9.  Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects.

Authors:  Peixin Yang; Xuezheng Li; Cheng Xu; Richard L Eckert; E Albert Reece; Horst Ronald Zielke; Fang Wang
Journal:  Sci Signal       Date:  2013-08-27       Impact factor: 8.192

Review 10.  No death without life: vital functions of apoptotic effectors.

Authors:  L Galluzzi; N Joza; E Tasdemir; M C Maiuri; M Hengartner; J M Abrams; N Tavernarakis; J Penninger; F Madeo; G Kroemer
Journal:  Cell Death Differ       Date:  2008-02-29       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.